Latest AI and machine learning research in urology for healthcare professionals.
PURPOSE: Emerging evidence suggests that the use of artificial intelligence can assist in the timely detection and optimization of therapeutic approach in patients with prostate cancer. The conventional perspective on radiomics encompassing segmentation and the extraction of radiomic features considers it as an independent and sequential process. However, it is not necessary to adhere to this view...
Prostate cancer is a dominant health concern calling for advanced diagnostic tools. Utilizing digital pathology and artificial intelligence, this stud...
Early identification of patients at high risk of cardiac surgery-associated acute kidney injury (CSA-AKI) is crucial for its prevention. We aimed to l...
BACKGROUND: Urothelial Bladder Cancer (UBC) is a common cancer with a high risk of recurrence, which is influenced by the TNM classification, grading,...
Forecasting the need for Renal Replacement Therapy (RRT) in intensive care units (ICUs) at an early stage can enhance patient outcomes and optimize re...
Open source, lightweight and offline generative large language models (LLMs) hold promise for clinical information extraction due to their suitability...
Introduction: Electrical impedance spectroscopy (EIS) has recently developed as a novel diagnostic device for screening and evaluating cervical dysp...
Cancer is a highly heterogeneous disease with significant variability in molecular features and clinical outcomes, making diagnosis and treatment ch...
CCCTC-binding factor (CTCF) is an insulator protein that binds to a highly conserved DNA motif and facilitates regulation of three-dimensional (3D) nu...
OBJECTIVE: Rectal toxicity is one of the primary dose-limiting side effects of prostate cancer radiotherapy, and consequential impairment on quality o...
Federated Learning (FL) has emerged as a promising solution to address the limitations of centralised machine learning (ML) in oncology, particularl...
To analyze the bibliometric publication trend on the application of "Artificial Intelligence (AI) and its subsets (Machine Learning-ML, Virtual reali...
Background Multiparametric MRI can help identify clinically significant prostate cancer (csPCa) (Gleason score ≥7) but is limited by reader experience...
The absence of predictive markers for kidney stone recurrence poses a challenge for the clinical management of stone disease. The unpredictability of...
BACKGROUND: Tumor mutation burden (TMB) and VHL mutation play a crucial role in the management of patients with clear cell renal cell carcinoma (ccRCC...
Breast cancer is a prevalent malignancy affecting women worldwide. Currently, there are no precise molecular biomarkers with immense potential for acc...
BACKGROUND: Robotic-assisted radical prostatectomy (RARP) is currently a first-line treatment option for men with localized prostate cancer (PCa), at ...
With the continuous advancement of artificial intelligence in the field of prostate cancer research, numerous studies have shown that AI performance c...
The development of omics technologies has driven a profound expansion in the scale of biological data and the increased complexity in internal dimensi...